This Wolfe isn't in sheep's clothing

March 2009
CMAJ: Canadian Medical Association Journal;3/4/2009 Doctor's Health Matters, Vol. 180, p584
Academic Journal
An interview with Dr. Sidney Wolfe of the consumer group United States Public Citizen is presented. When asked regarding any intellectual conflict of interest as safety committee member of the Food & Drug Administration (FDA), Wolfe states that he would not consider drug safety as a conflict. He challenged his critics to back their accusations that he is taking useful drugs off the market. He also states that the consortium who nominated him to the FDA appointment is a voluntary organization.


Related Articles

  • The politics of drug safety.  // Multinational Monitor;Sep99, Vol. 20 Issue 9, p23 

    Interviews Doctor Sidney Wolfe concerning the politics of drug safety. Origins of the United States drug regulatory system; Authority of the US Food and Drug Administration; Problems from inadequate drug regulatory system.

  • FDA is criticised for hinting at looser conflict of interest rules. Lenzer, Jeanne // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;8/13/2011, Vol. 343 Issue 7819, p338 

    No abstract available.

  • Ethics group wants FDA to drop two tobacco panel advisers over 'conflicts'. Pecquet, Julian // Hill;6/8/2010, Vol. 17 Issue 63, p18 

    The article reports that good-government group Citizens for Responsibility and Ethics in Washington is urging the U.S. Food and Drug Administration to dismiss two members of its advisory panel on tobacco products for financial conflicts of interests.

  • Conflicts of Interest Among Patient and Consumer Representatives to U.S. Food and Drug Administration Drug Advisory Committees. Graham, S. Scott; Card, Daniel J.; Seokhoon Ahn; Sang-Yeon Kim; Kessler, Molly M.; Olson, Michelle K.; Ahn, Seokhoon; Kim, Sang-Yeon // Annals of Internal Medicine;10/18/2016, Vol. 165 Issue 8, p606 

    A letter to the editor is presented in response to the article "Measuring conflict of interest and expertise on FDA advisory committees" by N. Ackerly in the December 10, 2013 issue.

  • Q and A: Dr. Sidney Wolfe, co-founder and director of Public Citizen's Health Research Group.  // Public Citizen News;Jul2011, Vol. 31 Issue 4, p10 

    An interview with the director of the Health Research Group of the Public Citizen organization, Sidney Wolfe is presented. When asked about his inspiration for working on dan­gerous drugs, he refers to his experiences at the National Institutes of Health (NIH) where he found that many unsafe...

  • Experts on the Take. Mokhiber, Russell // Multinational Monitor;Nov2000, Vol. 21 Issue 11, p29 

    Reveals that experts hired by the United States Food and Drug Administration have financial relationships with pharmaceutical companies. Percentage of experts with financial interest in the pharmacy industry or in topic they are asked to evaluate; Implications of their interests to the health...

  • FDA Seeks to Revamp Panels. Agres, Ted // Drug Discovery & Development;Aug2006, Vol. 9 Issue 8, p6 

    The article reports on the plan of the U.S. Food and Drug Administration to reassess how it selects and uses advisory committee members having potential financial conflicts of interest with pharmaceutical companies. FDA plans to hold a public hearing as a prelude to updating guidance on how it...

  • Conflict-of-Interest Policy Stymies Drug Review. Wechsler, Jill // Pharmaceutical Executive;Jan2010, Vol. 30 Issue 1, p16 

    The article reports on the move of the Food and Drug Administration (FDA) to seek panels/committee consisting of scientists and clinicians who can meet the stiffer conflict-of-interest standards in the U.S. As part of it, the FDA is screening 400 advisors and cleared 90 percent of them. The FDA...

  • News in brief.  // Nature;3/29/2007, Vol. 446 Issue 7135, p481 

    The article offers news briefs in the field of medical research. The US Food and Drug Administration (FDA) proposes tighter rules on conflicts of interest. Flu study faces shake-up over industry funding in Japan. Canada's science infrastructure got a boost with the release of the country's...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics